Who we are?

Folium is a vertically integrated, global cannabis company with cultivation and manufacturing assets in the USA and Colombia.

Through our distribution offices in Europe and Latin America, we are present in most markets where medical or adult-use cannabis is permitted, addressing a population of over 800 million people.

Our vision and strategy

industry

Industry

Cultivation commoditizing


Shift to non-smokeable products


Blurring boundaries between medical, recreational and health


Emerging brands


Opening of international markets

key

Key success factors

Low cost and scale


Product innovation


Customer
orientation


Digital and social media marketing


In-depth local regulatory insight

strategy

Folium strategy

Low-cost Colombian cultivation


Oil, concentrates and MIPS focus


Organization by
end markets


Dedicated online marketing team


Local partnerships

Medical division:

Foliumed Bogotá, Colombia

History

We started the application process for cultivation, extraction and export licences for psychoactive and non-psychoactive cannabis (CBD) in Q4 2017. Our decision to locate our medical division in Colombia has been based upon the country’s unique growing conditions, the availability of highly skilled human resources and a favorable, export- oriented regulatory framework.

Growth strategy

Following licence approval in Q3 2018, we will build out our 14 hectare cultivation and GMP extraction site in close proximity to Bogota. Our commercial strategy is to provide affordable, efficacy-proven prescription medicines and innovative OTC products to:

Latin America 

a market with

625 M people

where high cost LPs won’t be able to compete.

Major regulated import

markets such as

Germany or Canada

where demand outstrips supply

Facts and figures

Total cultivation capacity:

54 tons

of dried flower per annum

Total oil extraction capacity:

15 tons

of oil per annum

Adult use:

Strategic partnership with TapRoot Las Vegas, USA

History

TapRoot (www.taproot-holdings.com) is a vertically integrated cannabis company operating cultivation and extraction facilities in Las Vegas, Nevada. Commercial operations started in Q2 2017 with a focus on premium oil extraction (>90% THC) for third parties. By Q4, Taproot introduced its own branded Vape Pen line (“Roots”).

Growth strategy

TapRoot’s growth over the next 18-24 months will be driven by:

Product line expansion. We will broaden our product range beyond BtoB oil extraction and vape pens which account for less than 15% of total Nevada demand. Our product development pipeline includes concentrates, edibles and a premium flower Line.

Deeper retail penetration. As of today, our products are still on only 25% of Nevada’s dispensary sh elves, given the still recent start of our BtoC operations. Our distribution reach is now growing by 3-4 dispensaries per month, and re-orders from existing PoS are substantially increasing in size.

Dispensary licence. We will apply for a dispensary licence in H2 2018, and are partnering up with an experienced US cannabis retail operator with a track record of successful dispensary licence applications.

Facts and figures

Oil production capacity post 2018 expansion:

2000 kg/p.a.

BtoB market share:

15%

BtoB market share:

5%

Distribution reach:

25% of Nevada PoS

Our Products

Medical Products

Adult Use Products

Distribution and Consulting

Distribution

With global export markets for medical cannabis opening at a rapid pace, international distribution presence in high population jurisdictions with appropriate regulatory frameworks will become a key source of differentiation. Obtaining the relevant licences requires in-country physical presence and a detailed understanding of local regulations, administrative, security and compliance protocols. As of today, we have relevant assets in the following geographies:

USA: Medical product manufacturing and distribution licences (Nevada)

Canada: LOI with Canadian LP for import/export JV (50/50)

Germany: Application for wholesale narcotics import licences to be submitted Q3 2018

Brazil: 100% owned import and distribution company

Peru: 100% owned business development office

Consulting

Governmental authorities in jurisdictions aiming to establish a legal cannabis framework are looking for advice on how to best establish the necessary regulations to satisfy their specific objective. We are able to provide detailed know how to regulators and operators looking to expand their geographic reach. Our consultants have been keynote speakers at some of the leading cannabis conferences, including:

  • MJBizCon, Las Vegas
  • Lift Expo, Vancouver
  • Optionline Medical Cannabis, Sao Paulo
  • Cannabis Europe, London
  • NCIA Business Conference, New York
  • MJBizCon, Denver
  • Indoor Agriculture Conference, Las Vegas
  • California Growers Expo, Coachella Valley
  • Cannabis Economy, Vancouver
  • GreenTech, Amsterdam

Our Team

Oliver Zugel

Co-founder and Chairman

    • Former CEO of multinational gaming companies in Europe and Latam
    • Increased EBITDA from 70 to 300 M Euros and prepared IPO for a 2 bn USD company
    • Background in strategy consulting and PE with Michael Porter’s Monitor Company
    • 1st Class Degree from the LSE

Shane Terry

Co-founder, CEO USA

  • Co-founder of Taproot and CEO of several US cannabis companies
  • Former President of Nevada Dispensary Association and Board Member of cannabis company GB Sciences
  • #1 Flight Commander in the US Air Force for over 130,000 personnel

Oliver Markl

CFO

  • Former PE professional at Monitor
  • M&A advisor and Board member for European high tech companies
  • Investment banker at JP Morgan

Alfredo Pascual

VP Corporate Development

  • Founder of Transnational Cannabis Consultancy
  • Former Bus Dev for ICC Labs (TSX-V:ICC)
  • Degrees in Business Admin and Public Policy

Shane Terry

CEO Taproot Nevada

  • Co-founder of Taproot and CEO of several US cannabis companies
  • Former President of Nevada Dispensary Association and Board Member of cannabis company GB Sciences
  • #1 Flight Commander in the US Air Force for over 130,000 personnel

Tim Kelly

Operations Director

  • Business Director, Medical Practice
  • Project Manager and Training Consultant
  • Senior Leader, Air Force Retired 23.5 years
  • AMC Command Annual Award – #1 in career field

Derek Lopes

Lead Grower

  • 3rd generation cannabis grower
  • 40+ years experience in growing in Hawaii, California and Nevada
  • Unique breeding and genetics, access to unique strains
  • Premium Nevada lab certified strains from 26-30% THC

Joe Lapuma

Production Director

  • Certified master baker with 25 years experience
  • Founder of Nectar Organics, a Montana MIPS company
  • 7 years oil extraction, refinement and infusion of edibles
  • Expert in pharmacokinetic and pharmacodynamic processes and compounding topical formulations

Juan Velez

Cultivation Manager

  • Agricultural engineer graduated from Universidad Nacional de Colombia
  • Specialization in cannabis pest control

Henry Becerra

Extraction Manager

  • Chemical engineer graduated from Universidad Nacional de Colombia
  • Specialization in food biotechnology from Wageningen University in The Netherlands

Clay Hardin

Business Development, Peru

  • 25 years of business development expertise in US, LatAm and Asia
  • Senior executive at international, public gaming companies

Edgar Lenzi

Regulatory Affairs, Brazil

  • Founder of law firm Lenzi Advoacia
  • CEO of BetConsult, a gaming consultancy

Raul Buriticá

Regulatory Affairs, Colombia

  • Founder of law firm Buriticá Abogados
  • Expert in Colombian cannabis regulations

News

Foliumed Colombia to Supply Cannabis Extracts to Medisun Canada

Foliumed, a vertically integrated international producer of medicinal cannabis products has agreed to supply pharma-grade extracts to Medisun, an applicant under Health Canada’s licensing regime.

Veritas Pharma Signs R&D and Medical Cannabis Supply Agreement with Colombian Producer Foliumed S.A.S.

Under the terms of the MOU, Veritas and Foliumed will jointly conduct scientific research, undertake product development activities, and commercialize select medical cannabis products with the help of Veritas’ research […]

Contact us